These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26535530)

  • 21. Systemic mastocytosis.
    Karnam U; Rogers A
    Dig Dis; 1999; 17(5-6):299-307. PubMed ID: 10838487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptase Increase without Mastocytosis or Anaphylaxis.
    Ledford DK; Akin C
    J Allergy Clin Immunol Pract; 2017; 5(3):869. PubMed ID: 28483325
    [No Abstract]   [Full Text] [Related]  

  • 23. Congenital systemic mastocytosis.
    Date UG; Venugopal P; Kalgalwala TY; Rajani A; Parikh DA; Advani SH; Irani SF
    Indian Pediatr; 1989 Mar; 26(3):286-90. PubMed ID: 2568978
    [No Abstract]   [Full Text] [Related]  

  • 24. Strategies in childhood and adult mastocytosis.
    Kissling S; Kernland K; Gerbig AW; Hunziker T
    Dermatology; 1999; 198(4):426-30. PubMed ID: 10490305
    [No Abstract]   [Full Text] [Related]  

  • 25. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.
    Molderings GJ; Brettner S; Homann J; Afrin LB
    J Hematol Oncol; 2011 Mar; 4():10. PubMed ID: 21418662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to interpret mast cell tests.
    Waterfield T; Dyer E; Wilson K; Boyle RJ
    Arch Dis Child Educ Pract Ed; 2016 Oct; 101(5):246-51. PubMed ID: 27325614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihistamine syrups and alcohol.
    Murphy M; Watson R
    Pediatr Dermatol; 2001; 18(6):539. PubMed ID: 11841648
    [No Abstract]   [Full Text] [Related]  

  • 28. Mast Cell Activation Syndrome.
    Frieri M
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):353-365. PubMed ID: 25944644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic mastocytosis.
    Postgrad Med; 1972 Mar; 51(3):270. PubMed ID: 4401654
    [No Abstract]   [Full Text] [Related]  

  • 30. Carcinoid syndrome and disorders of systemic mast-cell activation including systemic mastocytosis.
    Roberts LJ
    Endocrinol Metab Clin North Am; 1988 Jun; 17(2):415-36. PubMed ID: 3042393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of systemic proliferative disease of mast cells (mastocytosis)].
    Hirnlowa L; Shwarek P; Wolek M
    Pol Tyg Lek; 1971 Feb; 26(8):279-80. PubMed ID: 4396316
    [No Abstract]   [Full Text] [Related]  

  • 32. Pseudoxanthomatous mastocytosis.
    Srivastava N; Chand S; Singh S
    Int J Dermatol; 2008 Jan; 47(1):50-1. PubMed ID: 18173602
    [No Abstract]   [Full Text] [Related]  

  • 33. [The clinical spectrum of mastocytosis].
    Langer K; Wolff K
    Hautarzt; 1990 Apr; 41(4):188-95. PubMed ID: 2192996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric mastocytosis.
    Kettelhut BV; Metcalfe DD
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):15S-18S; discussion 18S, 60S-65S. PubMed ID: 16799603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report.
    Malik F; Ali N; Jafri SIM; Ghani A; Hamid M; Boigon M; Fidler C
    J Med Case Rep; 2017 Apr; 11(1):119. PubMed ID: 28438191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burning mouth syndrome and mast cell activation disorder.
    Afrin LB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):465-72. PubMed ID: 21420635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists.
    Gasior-Chrzan B; Falk ES
    Dermatology; 1992; 184(2):149-52. PubMed ID: 1498379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Systemic mastocytosis and malignant mastocytosis].
    Lortholary O; Casassus P; Laroche L; Lortholary P; Diebold J
    Presse Med; 1990 Jan; 19(3):125-8. PubMed ID: 2137589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.